FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022389065> ?p ?o ?g. }

• W2022389065 endingPage "182" @default.
• W2022389065 startingPage "176" @default.
• W2022389065 abstract "Immunoreactive CRH concentrations were determined in human plasma using an immunoaffinity chromatographic extraction procedure and sensitive RIA. Immunoreactive CRH was detectable in the plasma of all normal subjects (mean +/- SD, 6.2 +/- 2.4 pg/mL; n = 15). Basal (0800-1000 h) plasma immunoreactive CRH levels were significantly lower in patients with Cushing's syndrome due to adrenal (2.8 +/- 1.1 pg/mL; n = 4) or pituitary adenomas (2.9 +/- 0.8 pg/mL; n = 5), in patients with hypothalamic hypopituitarism (3.2 +/- 0.9 pg/mL; n = 5), and in glucocorticoid-treated patients (3.9 +/- 1.9 pg/mL, n = 8). Basal plasma CRH levels were also low in patients with acromegaly (2.8 +/- 0.8 pg/mL; n = 14) and insulin-treated diabetic patients whose pituitary-adrenal function was normal (3.6 +/- 1.0 pg/mL; n = 12). In normal subjects plasma CRH levels increased after insulin-induced hypoglycemia; this response was abolished by the prior administration of dexamethasone. In contrast, basal plasma CRH levels were not affected by prior administration of metyrapone or dexamethasone. No evidence for diurnal variation in plasma immunoreactive CRH was found in normal subjects. In addition, in normal subjects oral glucose administration elicited a significant increase in plasma CRH (basal, 7.3 +/- 0.9 pg/mL; peak 30 min after glucose, 16.7 +/- 5.8 pg/mL; n = 5; P less than 0.05) without concomitant changes in ACTH. Gel filtration of extracts of pooled plasma from normal subjects revealed a major component of immunoreactive CRH in the position of synthetic rat CRH. Immunoreactive CRH-sized material had the same retention time as authentic rat CRH in a reverse phase high pressure liquid chromatography system. The content of immunoreactive CRH in human placenta, pancreas, and adrenal gland was much larger than that in hypothalamus. These findings suggest that immunoreactive CRH is present in peripheral plasma; the increase in plasma immunoreactive CRH after insulin-induced hypoglycemia may reflect stimulation of hypothalamic CRH release; the increase in plasma immunoreactive CRH after glucose administration may reflect extrahypothalamic CRH release; and the lack of diurnal variation in plasma immunoreactive CRH together with the lack of suppression of CRH by dexamethasone suggest that basal plasma CRH is of extrahypothalamic origin." @default.
• W2022389065 created "2016-06-24" @default.
• W2022389065 creator A5001334361 @default.
• W2022389065 creator A5001547186 @default.
• W2022389065 creator A5008928388 @default.
• W2022389065 creator A5032593664 @default.
• W2022389065 creator A5034763881 @default.
• W2022389065 creator A5039422855 @default.
• W2022389065 creator A5042175811 @default.
• W2022389065 creator A5047468489 @default.
• W2022389065 creator A5068264756 @default.
• W2022389065 creator A5075456686 @default.
• W2022389065 creator A5078110910 @default.
• W2022389065 date "1987-07-01" @default.
• W2022389065 modified "2023-09-30" @default.
• W2022389065 title "Immunoreactive Corticotropin-Releasing Hormone Present in Human Plasma May Be Derived from Both Hypothalamic and Extrahypothalamic Sources*" @default.
• W2022389065 cites W1493629431 @default.
• W2022389065 cites W2016025070 @default.
• W2022389065 cites W2016474338 @default.
• W2022389065 cites W2019595831 @default.
• W2022389065 cites W2021056897 @default.
• W2022389065 cites W2027057043 @default.
• W2022389065 cites W2034116199 @default.
• W2022389065 cites W2044395968 @default.
• W2022389065 cites W2045287102 @default.
• W2022389065 cites W2064666404 @default.
• W2022389065 cites W2066947713 @default.
• W2022389065 cites W2067856914 @default.
• W2022389065 cites W2086574534 @default.
• W2022389065 cites W2099749865 @default.
• W2022389065 cites W2132127993 @default.
• W2022389065 cites W2402515510 @default.
• W2022389065 cites W2081264545 @default.
• W2022389065 doi "https://doi.org/10.1210/jcem-65-1-176" @default.
• W2022389065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3294879" @default.
• W2022389065 hasPublicationYear "1987" @default.
• W2022389065 type Work @default.
• W2022389065 sameAs 2022389065 @default.
• W2022389065 citedByCount "76" @default.
• W2022389065 countsByYear W20223890652012 @default.
• W2022389065 countsByYear W20223890652013 @default.
• W2022389065 countsByYear W20223890652016 @default.
• W2022389065 countsByYear W20223890652017 @default.
• W2022389065 countsByYear W20223890652019 @default.
• W2022389065 countsByYear W20223890652022 @default.
• W2022389065 countsByYear W20223890652023 @default.
• W2022389065 crossrefType "journal-article" @default.
• W2022389065 hasAuthorship W2022389065A5001334361 @default.
• W2022389065 hasAuthorship W2022389065A5001547186 @default.
• W2022389065 hasAuthorship W2022389065A5008928388 @default.
• W2022389065 hasAuthorship W2022389065A5032593664 @default.
• W2022389065 hasAuthorship W2022389065A5034763881 @default.
• W2022389065 hasAuthorship W2022389065A5039422855 @default.
• W2022389065 hasAuthorship W2022389065A5042175811 @default.
• W2022389065 hasAuthorship W2022389065A5047468489 @default.
• W2022389065 hasAuthorship W2022389065A5068264756 @default.
• W2022389065 hasAuthorship W2022389065A5075456686 @default.
• W2022389065 hasAuthorship W2022389065A5078110910 @default.
• W2022389065 hasConcept C126322002 @default.
• W2022389065 hasConcept C134018914 @default.
• W2022389065 hasConcept C185592680 @default.
• W2022389065 hasConcept C2776719974 @default.
• W2022389065 hasConcept C2777433750 @default.
• W2022389065 hasConcept C2778024521 @default.
• W2022389065 hasConcept C2778458438 @default.
• W2022389065 hasConcept C2778491484 @default.
• W2022389065 hasConcept C2778709874 @default.
• W2022389065 hasConcept C2779306644 @default.
• W2022389065 hasConcept C2779435821 @default.
• W2022389065 hasConcept C2780401358 @default.
• W2022389065 hasConcept C2780668416 @default.
• W2022389065 hasConcept C2780841215 @default.
• W2022389065 hasConcept C2984496839 @default.
• W2022389065 hasConcept C71315377 @default.
• W2022389065 hasConcept C71924100 @default.
• W2022389065 hasConceptScore W2022389065C126322002 @default.
• W2022389065 hasConceptScore W2022389065C134018914 @default.
• W2022389065 hasConceptScore W2022389065C185592680 @default.
• W2022389065 hasConceptScore W2022389065C2776719974 @default.
• W2022389065 hasConceptScore W2022389065C2777433750 @default.
• W2022389065 hasConceptScore W2022389065C2778024521 @default.
• W2022389065 hasConceptScore W2022389065C2778458438 @default.
• W2022389065 hasConceptScore W2022389065C2778491484 @default.
• W2022389065 hasConceptScore W2022389065C2778709874 @default.
• W2022389065 hasConceptScore W2022389065C2779306644 @default.
• W2022389065 hasConceptScore W2022389065C2779435821 @default.
• W2022389065 hasConceptScore W2022389065C2780401358 @default.
• W2022389065 hasConceptScore W2022389065C2780668416 @default.
• W2022389065 hasConceptScore W2022389065C2780841215 @default.
• W2022389065 hasConceptScore W2022389065C2984496839 @default.
• W2022389065 hasConceptScore W2022389065C71315377 @default.
• W2022389065 hasConceptScore W2022389065C71924100 @default.
• W2022389065 hasIssue "1" @default.
• W2022389065 hasLocation W20223890651 @default.
• W2022389065 hasLocation W20223890652 @default.
• W2022389065 hasOpenAccess W2022389065 @default.
• W2022389065 hasPrimaryLocation W20223890651 @default.
• W2022389065 hasRelatedWork W2000765626 @default.

• next